Official announcements
Safety warnings
|
Blood & Tissue
|
12/07/2013
Number of cases increased to 201 ill persons by July 4, 2013 and thus now epidemic.
Recall
|
Medicines
|
11/07/2013
The marketing authorization holder informed its supplied customers in a letter dated July 9, 2013, that in the course of quality assurance measures it was determined that in batch 1200758 isolated ampoules with yellowish discolored contents and thus…
Replacement
|
Medicines
|
04/07/2013
The distribution partner "sanofi-aventis GmbH" informed its supplied customers in a letter dated 04.07.2013 that the retained samples of the above batch showed deviations. After a storage time of 26 months, aggregates above the permissible limit of…
Safety warnings
|
messages in brief
|
28/06/2013
Ergot derivatives (various preparations)
Recall
|
Veterinary Medicines
|
28/06/2013
The marketing authorization holder informed its supplied customers in a letter dated 17.06.2013 that a decrease in gentamicin content was observed in a batch of Soligental after 14 months of use (85.1%; specification: 95-105%) and that all batches of…
messages in brief
|
27/06/2013
More than 100 countries participated in this year's week of action against the illegal sale of medicines on the Internet. In total, more than nine million potentially dangerous medicines worth around 41 million US dollars were seized worldwide.…
messages in brief
|
26/06/2013
Please note that, with effect from 1 July 2013, product information texts should be submitted via the PHAROS eService "Marketing Authorisation & Lifecycle Management of Medicines" on https://eservices.basg.gv.at . By then, texts and documents are no…
Recall
|
Veterinary Medicines
|
26/06/2013
The distributor has informed its supplied customers in a letter dated 25.06.2013 that the following errors in the product labeling occurred in these batches and therefore a withdrawal from the market will take place: For "AviPro IB H52", the bottle…
messages in brief
|
26/06/2013
As of 02.07.2013, new regulations apply to the import of active ingredients for medicinal products for human use into the European Union. As of this date, active substances for medicinal products for human use may only be imported if at least one of…
Recall
|
Medicines
|
20/06/2013
The marketing authorization holder has informed its supplied customers in a letter dated June 19, 2013, that due to a manufacturing problem and the associated risk of microbial contamination with "Sphingomonas yanoikuyae", the above mentioned batches…